| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | EVP, General Counsel | Dec 13, 2019 | Option Exercise | $21.48 | 78,000 | 1,675,439 | 103,171 | Dec 17, 2019, 08:01 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | EVP, General Counsel | Dec 13, 2019 | Sale | $125.50 | 78,000 | 9,789,000 | 25,171 | Dec 17, 2019, 08:01 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Mahatme Sandesh | EVP, CFO & CBO | Dec 13, 2019 | Option Exercise | $28.88 | 125,000 | 3,610,443 | 155,179 | Dec 17, 2019, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Mahatme Sandesh | EVP, CFO & CBO | Dec 13, 2019 | Sale | $125.50 | 125,000 | 15,687,500 | 30,179 | Dec 17, 2019, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | EVP, General Counsel | Nov 22, 2019 | Sale | $105.00 | 25,000 | 2,625,000 | 18,703 | Nov 26, 2019, 08:01 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | EVP, General Counsel | Nov 22, 2019 | Option Exercise | $107.02 | 2,804 | 300,084 | 25,171 | Nov 26, 2019, 08:01 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | EVP, General Counsel | Nov 22, 2019 | Option Exercise | $16.13 | 34,272 | 552,667 | 36,993 | Nov 26, 2019, 08:01 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Barry Richard | Director | Sep 12, 2019 | Buy | $87.49 | 1,691 | 147,950 | 3,183,756 | Sep 16, 2019, 08:00 AM | |
| SRPT | Sarepta Therapeutics, Inc. | Barry Richard | Director | Sep 13, 2019 | Buy | $87.49 | 3,309 | 289,504 | 3,187,065 | Sep 16, 2019, 08:00 AM | |
| SRPT | Sarepta Therapeutics, Inc. | BONNEY MICHAEL W | Director | Sep 09, 2019 | Buy | $86.74 | 2,000 | 173,480 | 7,051 | Sep 09, 2019, 02:18 PM | |
| SRPT | Sarepta Therapeutics, Inc. | BEHRENS M KATHLEEN | Director | Sep 05, 2019 | Option Exercise | $7.80 | 5,000 | 39,000 | 123,167 | Sep 06, 2019, 02:13 PM | |
| SRPT | Sarepta Therapeutics, Inc. | BEHRENS M KATHLEEN | Director | Sep 06, 2019 | Buy | $87.98 | 2,500 | 219,950 | 125,667 | Sep 06, 2019, 02:13 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Mahatme Sandesh | EVP, CFO & CBO | Aug 21, 2019 | Option Exercise | $101.50 | 57,465 | 5,832,698 | 72,714 | Aug 22, 2019, 07:20 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Mahatme Sandesh | EVP, CFO & CBO | Aug 21, 2019 | Option Exercise | $23.85 | 100,000 | 2,385,000 | 130,179 | Aug 22, 2019, 07:20 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Barry Richard | Director | Aug 20, 2019 | Buy | $99.32 | 5,000 | 496,592 | 3,182,065 | Aug 20, 2019, 05:43 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Mahatme Sandesh | EVP, CFO & CBO | Aug 15, 2019 | Option Exercise | $24.73 | 9,754 | 241,232 | 30,179 | Aug 15, 2019, 04:33 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Barry Richard | Director | Aug 14, 2019 | Buy | $122.50 | 3,700 | 453,250 | 3,177,065 | Aug 14, 2019, 04:38 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Barry Richard | Director | Aug 12, 2019 | Buy | $122.50 | 1,300 | 159,250 | 3,173,365 | Aug 13, 2019, 04:31 PM | |
| SRPT | Sarepta Therapeutics, Inc. | INGRAM DOUGLAS S | President & CEO | Aug 12, 2019 | Buy | $123.07 | 16,252 | 2,000,160 | 432,197 | Aug 12, 2019, 05:48 PM | |
| SRPT | Sarepta Therapeutics, Inc. | O'Neill Gilmore Neil | EVP, R&D & CMO | May 24, 2019 | Option Exercise | $119.31 | 4,630 | 552,405 | 7,370 | May 24, 2019, 08:07 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Wigzell Hans Lennart Rudolf | Director | May 23, 2019 | Option Exercise | $7.80 | 10,000 | 78,000 | 21,717 | May 24, 2019, 08:03 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Wigzell Hans Lennart Rudolf | Director | May 23, 2019 | Sale | $120.00 | 10,000 | 1,200,000 | 11,717 | May 24, 2019, 08:03 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Mahatme Sandesh | EVP, CFO & CBO | Mar 28, 2019 | Option Exercise | $118.68 | 2,953 | 350,462 | 20,425 | Mar 29, 2019, 08:01 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | EVP, General Counsel | Mar 28, 2019 | Option Exercise | $118.68 | 2,362 | 280,322 | 18,703 | Mar 29, 2019, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Cumbo Alexander | EVP, Chief Commercial Officer | Mar 28, 2019 | Option Exercise | $118.68 | 2,165 | 256,942 | 11,161 | Mar 29, 2019, 07:59 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Mahatme Sandesh | EVP, CFO & CBO | Mar 19, 2019 | Option Exercise | $21.46 | 15,486 | 332,308 | 19,354 | Mar 20, 2019, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Mahatme Sandesh | EVP, CFO & CBO | Mar 19, 2019 | Option Exercise | $126.47 | 2,625 | 331,984 | 16,729 | Mar 20, 2019, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Mahatme Sandesh | EVP, CFO & CBO | Feb 07, 2019 | Option Exercise | $23.85 | 65,000 | 1,550,250 | 73,649 | Feb 08, 2019, 08:02 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Mahatme Sandesh | EVP, CFO & CBO | Feb 07, 2019 | Sale | $145.00 | 65,000 | 9,425,000 | 8,649 | Feb 08, 2019, 08:02 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Cumbo Alexander | SVP, Chief Commercial Officer | Feb 01, 2019 | Option Exercise | $22.54 | 7,500 | 169,035 | 30,266 | Feb 01, 2019, 08:27 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Cumbo Alexander | SVP, Chief Commercial Officer | Feb 01, 2019 | Sale | $140.00 | 15,000 | 2,100,000 | 15,266 | Feb 01, 2019, 08:27 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Feb 01, 2019 | Option Exercise | $21.65 | 21,500 | 465,391 | 49,571 | Feb 01, 2019, 08:25 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Feb 01, 2019 | Sale | $140.00 | 30,000 | 4,200,000 | 19,571 | Feb 01, 2019, 08:25 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Mahatme Sandesh | EVP, CFO & CBO | Jan 30, 2019 | Sale | $130.00 | 43,802 | 5,694,260 | 8,649 | Feb 01, 2019, 08:24 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Mahatme Sandesh | EVP, CFO & CBO | Jan 31, 2019 | Option Exercise | $23.85 | 21,198 | 505,572 | 29,847 | Feb 01, 2019, 08:24 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Mahatme Sandesh | EVP, CFO & CBO | Jan 31, 2019 | Sale | $130.72 | 21,198 | 2,771,003 | 8,649 | Feb 01, 2019, 08:24 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Mahatme Sandesh | EVP, CFO & CBO | Jan 30, 2019 | Option Exercise | $18.27 | 43,802 | 800,077 | 52,451 | Feb 01, 2019, 08:24 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Wigzell Hans Lennart Rudolf | Director | Nov 01, 2018 | Option Exercise | $8.94 | 6,667 | 59,603 | 16,751 | Nov 02, 2018, 06:01 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Wigzell Hans Lennart Rudolf | Director | Nov 01, 2018 | Sale | $140.50 | 6,667 | 936,714 | 10,084 | Nov 02, 2018, 06:01 PM | |
| SRPT | Sarepta Therapeutics, Inc. | BEHRENS M KATHLEEN | Director | Oct 31, 2018 | Option Exercise | $3.96 | 10,000 | 39,600 | 126,534 | Nov 02, 2018, 06:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | BEHRENS M KATHLEEN | Director | Oct 31, 2018 | Sale | $131.71 | 10,000 | 1,317,100 | 116,534 | Nov 02, 2018, 06:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | INGRAM DOUGLAS S | President & CEO | Oct 30, 2018 | Buy | $120.39 | 16,695 | 2,009,872 | 415,945 | Oct 30, 2018, 07:05 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Mahatme Sandesh | EVP, CFO & CBO | Oct 24, 2018 | Option Exercise | $14.88 | 89,400 | 1,330,389 | 128,185 | Oct 26, 2018, 06:43 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Mahatme Sandesh | EVP, CFO & CBO | Oct 24, 2018 | Sale | $127.74 | 107,524 | 13,735,116 | 20,661 | Oct 26, 2018, 06:43 PM | |
| SRPT | Sarepta Therapeutics, Inc. | INGRAM DOUGLAS S | President & CEO | Aug 15, 2018 | Buy | $125.26 | 16,000 | 2,004,208 | 399,250 | Aug 16, 2018, 07:30 AM | |
| SRPT | Sarepta Therapeutics, Inc. | Cumbo Alexander | SVP, Chief Commercial Officer | Aug 08, 2018 | Option Exercise | $121.02 | 6,000 | 726,120 | 22,766 | Aug 08, 2018, 06:16 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Aug 08, 2018 | Option Exercise | $121.02 | 6,800 | 822,936 | 28,071 | Aug 08, 2018, 06:14 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Mahatme Sandesh | EVP, CFO & CBO | Aug 08, 2018 | Option Exercise | $121.02 | 8,501 | 1,028,791 | 38,785 | Aug 08, 2018, 06:14 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Jul 16, 2018 | Option Exercise | $13.85 | 50,000 | 692,691 | 72,719 | Jul 17, 2018, 06:01 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Jul 16, 2018 | Sale | $136.46 | 50,000 | 6,823,000 | 34,871 | Jul 17, 2018, 06:01 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Cumbo Alexander | SVP, Chief Commercial Officer | Jul 09, 2018 | Option Exercise | $13.78 | 33,782 | 465,415 | 40,690 | Jul 11, 2018, 06:05 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Cumbo Alexander | SVP, Chief Commercial Officer | Jul 09, 2018 | Sale | $137.32 | 33,782 | 4,638,944 | 28,766 | Jul 11, 2018, 06:05 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Barry Richard | Director | Jun 27, 2018 | Sale | $130.34 | 75,000 | 9,775,500 | 3,170,432 | Jun 29, 2018, 06:01 PM | |
| SRPT | Sarepta Therapeutics, Inc. | INGRAM DOUGLAS S | President & CEO | Jun 26, 2018 | Option Exercise | $135.53 | 36,946 | 5,007,291 | 383,250 | Jun 27, 2018, 05:24 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Ruff Shamim | SVP, Chief Regulatory Affairs | May 22, 2018 | Option Exercise | $89.22 | 1,305 | 116,432 | 31,936 | May 24, 2018, 06:06 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Mahatme Sandesh | EVP, CFO & CBO | May 22, 2018 | Option Exercise | $89.22 | 2,024 | 180,581 | 47,286 | May 24, 2018, 06:05 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | May 22, 2018 | Option Exercise | $89.22 | 1,566 | 139,719 | 34,871 | May 24, 2018, 06:05 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Cumbo Alexander | SVP, Chief Commercial Officer | May 22, 2018 | Option Exercise | $89.22 | 1,435 | 128,031 | 28,766 | May 24, 2018, 06:04 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Ruff Shamim | SVP, Chief Regulatory Affairs | Mar 15, 2018 | Option Exercise | $81.22 | 736 | 59,778 | 28,809 | Mar 16, 2018, 06:13 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Ruff Shamim | SVP, Chief Regulatory Affairs | Mar 15, 2018 | Option Exercise | $23.93 | 2,500 | 59,813 | 29,465 | Mar 16, 2018, 06:13 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Mar 15, 2018 | Option Exercise | $81.22 | 680 | 55,230 | 31,118 | Mar 16, 2018, 06:12 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Mar 15, 2018 | Option Exercise | $22.15 | 2,500 | 55,382 | 31,727 | Mar 16, 2018, 06:12 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Cumbo Alexander | SVP, Chief Commercial Officer | Mar 15, 2018 | Option Exercise | $20.64 | 2,500 | 51,600 | 25,767 | Mar 16, 2018, 06:10 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Cumbo Alexander | SVP, Chief Commercial Officer | Mar 15, 2018 | Option Exercise | $81.22 | 633 | 51,412 | 25,325 | Mar 16, 2018, 06:10 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Mahatme Sandesh | EVP, CFO & CBO | Mar 15, 2018 | Option Exercise | $81.22 | 734 | 59,615 | 42,661 | Mar 16, 2018, 06:08 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Mahatme Sandesh | EVP, CFO & CBO | Mar 15, 2018 | Option Exercise | $23.85 | 2,500 | 59,625 | 43,395 | Mar 16, 2018, 06:08 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Wigzell Hans Lennart Rudolf | Director | Nov 30, 2017 | Option Exercise | $7.38 | 6,667 | 49,202 | 13,333 | Dec 04, 2017, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Wigzell Hans Lennart Rudolf | Director | Nov 30, 2017 | Sale | $55.89 | 6,667 | 372,619 | 6,666 | Dec 04, 2017, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | INGRAM DOUGLAS S | President & CEO | Nov 08, 2017 | Buy | $52.44 | 38,138 | 1,999,957 | 420,196 | Nov 13, 2017, 05:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Ruff Shamim | SVP, Regulatory Affairs & Qual | Nov 06, 2017 | Option Exercise | $14.76 | 10,000 | 147,600 | 37,045 | Nov 08, 2017, 08:13 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Ruff Shamim | SVP, Regulatory Affairs & Qual | Nov 06, 2017 | Sale | $55.00 | 10,000 | 550,000 | 27,045 | Nov 08, 2017, 08:13 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Ruff Shamim | SVP, Regulatory Affairs & Qual | Oct 03, 2017 | Option Exercise | $14.76 | 11,500 | 169,740 | 38,545 | Oct 05, 2017, 07:24 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Ruff Shamim | SVP, Regulatory Affairs & Qual | Oct 03, 2017 | Sale | $50.00 | 11,500 | 575,000 | 27,045 | Oct 05, 2017, 07:24 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Ruff Shamim | SVP, Regulatory Affairs & Qual | Aug 03, 2017 | Option Exercise | $37.88 | 2,882 | 109,170 | 27,045 | Aug 07, 2017, 04:44 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Mahatme Sandesh | EVP, CFO & CBO | Aug 03, 2017 | Option Exercise | $37.88 | 6,264 | 237,280 | 40,895 | Aug 07, 2017, 04:42 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Aug 03, 2017 | Option Exercise | $37.88 | 4,642 | 175,839 | 29,298 | Aug 07, 2017, 04:40 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Kaye Edward M. MD | Director | Aug 03, 2017 | Option Exercise | $37.88 | 16,703 | 632,710 | 71,229 | Aug 07, 2017, 04:39 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Cumbo Alexander | SVP, Chief Commercial Officer | Aug 03, 2017 | Option Exercise | $37.88 | 3,169 | 120,042 | 23,458 | Aug 07, 2017, 04:38 PM | |
| SRPT | Sarepta Therapeutics, Inc. | INGRAM DOUGLAS S | President & CEO | Jul 27, 2017 | Buy | $42.50 | 47,058 | 1,999,965 | 382,058 | Jul 28, 2017, 08:51 AM | |
| SRPT | Sarepta Therapeutics, Inc. | Mahatme Sandesh | EVP, CFO & CBO | Jul 20, 2017 | Option Exercise | $15.38 | 50,000 | 769,107 | 65,359 | Jul 21, 2017, 09:49 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Mahatme Sandesh | EVP, CFO & CBO | Jul 20, 2017 | Sale | $41.00 | 50,000 | 2,050,000 | 32,361 | Jul 21, 2017, 09:49 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Mahatme Sandesh | EVP, CFO & CBO | Jul 21, 2017 | Option Exercise | $23.85 | 1,500 | 35,775 | 33,861 | Jul 21, 2017, 09:49 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Kaye Edward M. MD | Director | Jul 20, 2017 | Option Exercise | $40.93 | 4,349 | 178,005 | 62,471 | Jul 21, 2017, 09:48 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Kaye Edward M. MD | Director | Jul 20, 2017 | Sale | $41.00 | 10,000 | 410,000 | 52,471 | Jul 21, 2017, 09:48 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Ruff Shamim | SVP, Regulatory Affairs & Qual | Jul 20, 2017 | Option Exercise | $13.71 | 6,250 | 85,688 | 27,312 | Jul 21, 2017, 09:47 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Ruff Shamim | SVP, Regulatory Affairs & Qual | Jul 20, 2017 | Sale | $42.00 | 6,250 | 262,500 | 21,062 | Jul 21, 2017, 09:47 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Ruff Shamim | SVP, Regulatory Affairs & Qual | Jul 21, 2017 | Option Exercise | $14.12 | 5,888 | 83,133 | 25,450 | Jul 21, 2017, 09:47 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Ruff Shamim | SVP, Regulatory Affairs & Qual | Jul 21, 2017 | Sale | $44.00 | 5,888 | 259,072 | 21,062 | Jul 21, 2017, 09:47 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Jul 21, 2017 | Option Exercise | $20.56 | 1,000 | 20,565 | 23,301 | Jul 21, 2017, 09:46 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Jul 20, 2017 | Option Exercise | $13.71 | 25,000 | 342,750 | 41,357 | Jul 21, 2017, 09:46 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Jul 20, 2017 | Sale | $41.00 | 25,000 | 1,025,000 | 22,301 | Jul 21, 2017, 09:46 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Cumbo Alexander | SVP, Chief Commercial Officer | Jul 20, 2017 | Option Exercise | $13.71 | 2,500 | 34,275 | 22,793 | Jul 21, 2017, 09:45 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Cumbo Alexander | SVP, Chief Commercial Officer | Jul 20, 2017 | Sale | $41.00 | 5,918 | 242,638 | 20,293 | Jul 21, 2017, 09:45 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Kaye Edward M. MD | President & CEO | Apr 20, 2017 | Option Exercise | $32.54 | 4,349 | 141,516 | 66,820 | Apr 24, 2017, 05:11 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Mar 19, 2017 | Option Exercise | $30.30 | 152 | 4,606 | 22,301 | Mar 21, 2017, 06:07 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Mahatme Sandesh | EVP, CFO & CBO | Mar 19, 2017 | Option Exercise | $30.30 | 171 | 5,181 | 32,361 | Mar 21, 2017, 06:05 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Ruff Shamim | SVP, Regulatory Affairs & Qual | Mar 19, 2017 | Option Exercise | $30.30 | 177 | 5,363 | 21,062 | Mar 21, 2017, 06:01 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Kaye Edward M. MD | President, CEO & CMO | Jan 20, 2017 | Option Exercise | $32.66 | 4,466 | 145,860 | 71,169 | Jan 24, 2017, 05:52 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Nov 09, 2016 | Option Exercise | $23.85 | 1,000 | 23,850 | 22,453 | Nov 10, 2016, 08:27 AM | |
| SRPT | Sarepta Therapeutics, Inc. | Mahatme Sandesh | Senior Vice President, CFO | Nov 09, 2016 | Option Exercise | $23.85 | 1,000 | 23,850 | 32,532 | Nov 10, 2016, 08:26 AM |
Menu